Clean, Safe, Effective


MicroDerm™ is a commercial transdermal patch application that utilizes microneedle technology to deliver a wide range of drugs to patients. The patch, with tiny microneedles, penetrates the skin just enough to enable the drug to enter the bloodstream, but not so far as to create the pain or inconvenience associated with hypodermic needles.

The biggest impact MicroDerm™ will have is providing safe, effective alternatives to needles and shots—relating to vaccines, diabetes management, large molecule delivery, protein and peptide delivery, and biologics.

Partner With Us

Partnering for Patient Success


As an expert in transdermal patch formulation, design, development, and manufacturing, Tapemark recognizes the opportunity as a transdermal CDMO to continue to prioritize innovation in the pharmaceutical industry. In an effort to commercialize MicroDerm™, we’ve entered a strategic partnership with 10x Technology, a micro-structured solution company from Illinois, founded in 2005.

10x Technology provides Tapemark with a sustainable manufacturing process ensuring consistent and precision replication of MicroDerm™. The dual investment in transdermal pharmaceutical research and development benefits patients around the world suffering from unmet needs due to various diseases and medical ailments.

How are partnerships approached?

We approach partnerships with an eye for synergy: our strengths paired with their strengths to create a new offering or concept that might be too big of an initiative to develop on our own. The vetting process involves market analysis, competitor analysis, technical analysis, and most importantly people analysis—of who are we working with.

100 - 2,000

Range of needles on a patch

20

Years of product and process development

Benefits of MicroDerm™


  • Delivery of large molecules previously not deliverable with traditional transdermal systems
  • Greater bioavailability of active ingredients vs oral administration
  • Fewer side effects vs oral administration
  • New therapeutics not previously administered via transdermal delivery due to molecule and permeation limits
  • Improved compliance to dosing schedules vs oral administration
  • Better outcomes via improved pharmacokinetic profiles and greater compliance
  • Lower system healthcare spend given better outcomes in the target population
Looking to discuss your project with a formulation development expert? Talk to Marina
Transdermal Patch Production Image
employee measuring
MicroDerm patches
production line

What Our Partners Have to Say

"Tapemark has proven itself as a leader in development and manufacturing of pharmaceutical thin films. The team at Tapemark has been an invaluable partner in their expertise provided to support our technology transfers. They continue to be committed to the success of each of our projects."

Joe T – Senior Director, Technical Operations
Medium Size Branded Pharmaceutical Company

“We have partnered with Tapemark over the years for our transdermal patch projects. We have found Tapemark to be a great partner. Tapemark has become a one stop shop for transdermal product development and commercial manufacturing after expanding its capabilities.”

J.W. – Senior Director R&D
Medium Size Branded Pharmaceutical Company

“The Tapemark team met every technical challenge and applied the extra resources necessary for us to achieve a successful launch of one of our strategic products."

John B – VP External Operations
Large Generics Pharmaceutical Company

"We have partnered with Tapemark for several business-critical new product launches. We have found Tapemark to be flexible and customer-focused and willing to accommodate our changing needs to their best ability. It has been a pleasure working with the Tapemark team."

K.B. – VP Supply Chain
Global Generic Pharmaceutical Company

"We have partnered with Tapemark for our transdermal patch since 2013. We have found Tapemark to be a highly experienced and professional team. The most important aspect is however the collaboration between our companies in building a solid foundation for our partnership, mutual respect, and success in business."

K.R. – VP Commercial Ops
Small Specialty Branded Pharmaceutical Company

"We have been a supplier to Tapemark for over 7 years and in our experience, the people at Tapemark are a pleasure to work with. We have created a mutually beneficial business relationship by working through all aspects of the supply chain. Our mutual commitment to meet regularly helps us plan together and has been very beneficial to ensure that we meet all the requirements established by Tapemark. Working with a company like Tapemark is rewarding for us and we are honored to participate in your mission by playing a role to assist in the delivery of non-invasive products that aid in pain treatment."

D.C. – VP Sales and Marketing
Large Packaging Supplier

"Tapemark is a great customer and we have the utmost confidence to refer you."

D.C. – VP Sales
Technical Components Supplier
Explore Our In-Depth Guide to Pharmaceutical CDMOs Start Exploring